Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Corvus Pharmaceuticals	Xeris Pharmaceuticals	ProMetic Life Sciences	TapImmune	AcelRx Pharmaceuticals
Symbol	NASDAQ:CRVS	NASDAQ:XERS	OTCMKTS:PFSCF	NASDAQ:MRKR	NASDAQ:ACRX
Price Information
Current Price	$2.05	$1.88	$0.01	$1.72	$1.28
52 Week Range	Buy	Buy	Hold	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Buy	Buy
Consensus Price Target	$7.75	$16.00	N/A	$10.33	$6.38
% Upside from Price Target	278.05% upside	751.06% upside	N/A	500.78% upside	397.97% upside
Trade Information
Market Cap	$61.89 million	$74.76 million	$338,000.00	$83.29 million	$84.43 million
Beta	2.04	1.15	2.46	0.2	1.66
Average Volume	154,493	568,729	174	293,300	1,222,494
Sales & Book Value
Annual Revenue	N/A	$2.72 million	$36.55 million	$210,000.00	$2.29 million
Price / Sales	N/A	25.97	0.01	381.10	44.95
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.42 per share	$0.53 per share	($67.63) per share	$0.96 per share	($0.52) per share
Price / Book	N/A	3.55	0.00	1.79	-2.46
Profitability
Net Income	$-46,670,000.00	$-125,580,000.00	$-150,730,000.00	$-21,430,000.00	$-53,240,000.00
EPS	($1.59)	($4.81)	N/A	($0.47)	($0.67)
Trailing P/E Ratio	N/A	N/A	0.00	N/A	N/A
Forward P/E Ratio	N/A	N/A	∞	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-4,568.21%	-894.02%	N/A	-2,325.91%
Return on Equity (ROE)	-54.61%	-209.32%	-3,350.55%	-43.07%	N/A
Return on Assets (ROA)	-47.68%	-94.43%	-67.76%	-40.48%	-50.12%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.03%	4.04%	N/A	0.01%	N/A
Current Ratio	7.76%	3.20%	0.95%	22.82%	5.27%
Quick Ratio	7.76%	3.12%	0.71%	22.82%	5.02%
Ownership Information
Institutional Ownership Percentage	70.89%	46.94%	0.10%	33.21%	23.03%
Insider Ownership Percentage	40.40%	7.43%	N/A	23.70%	7.50%
Miscellaneous
Employees	49	90	487	11	61
Shares Outstanding	29.33 million	37.57 million	23.31 million	46.53 million	80.41 million
Next Earnings Date	5/14/2020 (Estimated)	5/14/2020 (Estimated)	N/A	5/14/2020 (Estimated)	5/13/2020 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources